1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot): new trials by email Literature Review of Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot) trials Research Report on Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques Application of new pulse sequence package SIGNATURES2023 to healthy controls, Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot) - Aging, Brain Metabolic Disorder | Not applicable | Not yet recruiting | Insel Gruppe AG, University Hospital Bern | 140 | 2025-04-01 | 2025-03-25 |
Alzheimer Disease (1) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Carotid Stenosis (1) · Cognitive Dysfunction (1) · Diabetes Mellitus, Type 2 (1)
Insel Gruppe AG, University Hospital Bern (1)
Switzerland (1)